Christopher Martell

Insider Reports History

Location
Needham, MA
Signature
/s/ Charles Schoch, as Attorney-In-Fact for Christopher Martell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Martell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. Director Common Stock 284K $1.36M $4.81 Jun 25, 2025 By GTAM1 2012 ADV LLC
Candel Therapeutics, Inc. Director Common Stock 152K $731K $4.81 Jun 25, 2025 By GTAM1 2012 LLC
Candel Therapeutics, Inc. Director Common Stock 111K $520K $4.67 Jun 25, 2025 By Spouse
Candel Therapeutics, Inc. Director Stock Option (Right to Buy) 14.2K Jun 17, 2025 Direct

Insider Reports Filed by Christopher Martell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CADL Candel Therapeutics, Inc. Jun 25, 2025 1 $520K 4 Jun 26, 2025 Director
CADL Candel Therapeutics, Inc. Jun 17, 2025 1 $0 4 Jun 18, 2025 Director
CADL Candel Therapeutics, Inc. Jun 26, 2024 1 $0 4 Jun 27, 2024 Director
CADL Candel Therapeutics, Inc. Jun 28, 2023 1 $0 4 Jun 29, 2023 Director
CADL Candel Therapeutics, Inc. Dec 8, 2022 2 $51.1K 4/A Feb 17, 2023 Director
CADL Candel Therapeutics, Inc. Oct 13, 2022 1 $0 4 Oct 17, 2022 Director
CADL Candel Therapeutics, Inc. Jul 29, 2021 3 $1M 4 Aug 2, 2021 Director
CADL Candel Therapeutics, Inc. Jul 26, 2021 0 $0 3 Jul 26, 2021 Director